Adults 75 and older who stopped statins had similar three-year survival, trial finds

by Lancet

edited by Lisa Lock, reviewed by Alexander Pol

Lisa Lock

Scientific Editor

Meet our editorial team
Behind our editorial process

Alexander Pol

Deputy Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

The GIST Add as preferred source

Stopping statins in adults 75 and older with no history of heart disease or stroke does not increase the risk of death over three years compared with continuing statins, although "bad" cholesterol rose around 50% in those who stopped, according to a randomized controlled trial published in The Lancet Healthy Longevity. Statins are a key medication for the prevention of atherosclerotic cardiovascular disease, a specific type of cardiovascular disease caused by the buildup of fatty plaque (atherosclerosis) inside the arteries.

In 2013, a Cochrane meta-analysis of 18 trials lasting up to five years reported a 14% reduction in deaths from all causes in adults taking statins for primary prevention of atherosclerotic cardiovascular disease with a median age of 57 years. However, most trials looking at statins exclude individuals older than 70 or 80 years; therefore, the benefit of statins for primary prevention of heart disease or stroke in older populations remains unclear.

The new trial enrolled 1,160 adults 75 and older with no history of heart disease or stroke across general practices in France, randomly assigning them to either stop or continue their statin medication.

After three years, 7.2% (35/484) of adults in the statin discontinuation group had died, compared with 7.9% (48/604) in the continuation group. There was no significant difference in major cardiovascular events, including heart attacks and strokes, between those who stopped statins and those who continued over the three years.

However, after three months, there was an average 50% increase (115 mg/dL to 171 mg/dL) in "bad" (LDL) cholesterol among adults who stopped statins, while the group that continued taking statins had no change. Additionally, the study found measures of quality of life, both physical and mental, stayed the same for both groups during the three-year follow-up.

The authors say the benefits of statins increase over time in younger adults, and it remains unknown whether stopping the medication could increase the risk of cardiovascular disease and death after the three-year follow-up period in older people.

They caution that this study does not mean older patients with no history of heart disease or stroke should systematically stop taking their statins—the decision to continue or stop statin treatment in later life should be an individualized, shared decision-making process between patients and clinicians. Further trials are needed to confirm these findings and assess the long-term effect of stopping statins in older adults.

More information

Fabrice Bonnet et al, Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial, The Lancet Healthy Longevity (2026). DOI: 10.1016/j.lanhl.2026.100884

Key medical concepts

DeathAtherosclerosis

Clinical categories

CardiologyHealthy agingGeriatric palliative careFamily medicine Provided by Lancet Who's behind this story?

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Alexander Pol

PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →

Citation: Adults 75 and older who stopped statins had similar three-year survival, trial finds (2026, August 12) retrieved 12 August 2026 from https://medicalxpress.com/news/2026-08-adults-older-statins-similar-year.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.